回复 齐欢畅2 的帖子
最新新闻Romark的硝唑尼特。他们正在测试C型肝炎硝唑尼特，而不是B型肝炎
治疗结合Romark的硝唑尼特与Intercell的侦查丙型肝炎疫苗;第二期临床试验开始到上半年2011Treatment结合Romark与Intercell的丙型肝炎疫苗研究用硝唑尼特;二期临床试验2011年上半年开始
坦帕，佛罗里达州，10月21日/新华美通/ - Romark实验室，立法会与Intercell公司（的VSE，“ICLL”）今天宣布计划开始与Intercell的研究性治疗丙型肝炎病毒（HCV）的疫苗，IC41，组合在2011年上半年Romark的抗病毒药物，硝唑尼特，临床试验。
了解更多：Romark和Intercell加入抗丙型肝炎http://www.medindia.net/health-p ... -Against-Hepatitis-力相结合疗法的C - 83595 - 1.htm＃ixzz134o9w276
Latest news from Romark's Nitazoxanide. They are testing Nitazoxanide for Hepatitis C, not for Hepatitis B.
Treatment to Combine Romark's Nitazoxanide with Intercell's Investigational Hepatitis C Vaccine; Phase II Clinical Trials Beginning 1H 2011Treatment to Combine Romark's Nitazoxanide with Intercell's Investigational Hepatitis C Vaccine; Phase II Clinical Trials Beginning 1H 2011
TAMPA, Fla., Oct. 21 /PRNewswire/ -- Romark Laboratories, L.C. and Intercell AG (VSE; "ICLL") today announced plans to commence clinical trials of Romark's antiviral drug, nitazoxanide, in combination with Intercell's investigational therapeutic hepatitis C virus (HCV) vaccine, IC41, during the first half of 2011.
Read more: Romark and Intercell Join Forces in Combining Therapies Against Hepatitis C http://www.medindia.net/health-press-release/Romark-and-Intercell-Join-Forces-in-Combining-Therapies-Against-Hepatitis-C-83595-1.htm#ixzz134o9w276
| 
楼主: 闹心啊
发表于 2010-10-22 16:35
